At 6.5% CAGR, Global Cardiac POC Testing Market Size & Share Surpass US$ 2.89 Bn| 2030, Forecast & Analysis Report | CMI
Custom Market Insights?
Accelerate Strategy Execution and Consistency in Revenue Growth!!
According to the study, The?Global Cardiac POC Testing Market?was estimated at USD 1.2 Billion in 2021 and is anticipated to reach around USD 2.89 Billion by 2030, growing at a CAGR of roughly 6.5% between 2027 and 2030.
Overview:
Cardiac POC testing is a diagnostic test that is especially related to the heart and is carried out at or near the point of care of the patient.
POC testing is a blood diagnostic test used to detect cholesterol and blood coagulation in the body. This diagnostic test helps physicians to examine the risk of developing thrombosis and coagulation inside a blood vessel, which leads to cardiac arrest.
Furthermore, cardiac POC testing involves troponin and brain natriuretic peptide analysis tests to identify cardiovascular disorders such as myocardial infarction, coronary artery disease, and heart failure. The Cardiac POC test is time effective. For instance, in most cases, diagnosis reports are provided within an hour after the submission of test samples. The demand for cardiac POC testing will drive during the forecast period.
?Growth Drivers:
Increasing heart-related disorders among people will drive cardiac POC testing thus, increases the overall potential sale of POC testing across the globe. For instance, according to an article published by the National Medicine Library in July 2020, Ischemic Heart Disease ( IHD )affects around 126 million individuals (1,655 per 100,000), which is approximately 1.72% of the world’s population. The overall demand for the cardiac POIC testing market will be expected to grow exponentially.